The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 168.00
Bid: 167.80
Ask: 168.00
Change: 3.60 (2.19%)
Spread: 0.20 (0.119%)
Open: 167.00
High: 168.20
Low: 165.40
Prev. Close: 164.40
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

27 Apr 2018 13:14

RNS Number : 4279M
Forterra plc
27 April 2018
 

27 April 2018

Forterra plc

PDMR Shareholdings

Forterra plc (the "Company") was notified on 26 April 2018 that on the same day Matthew Clay, Managing Director, Bespoke Products and Darren Rix, Strategy and Development Director both of whom are defined as Persons Discharging Management Responsibilities (PDMR's) exercised share options over the Company's ordinary shares of 1p each ("ordinary shares") granted under the Forterra Deferred Annual Bonus Plan.

The options were granted as nominal (1p) cost options although this sum was waived by the Company on exercise. The number of options exercised also includes a dividend equivalent in addition to the options initially granted in accordance with the rules of the scheme. On exercise, sufficient shares were immediately sold to cover tax, NI and transaction costs.

No new shares were issued in respect of these transactions with the shares being transferred to the individuals from the Forterra Employee Benefit Trust.

Name

Number of options exercised

Number of shares transferred to individual after paying tax, NI and transaction costs

Number of shares now beneficially held by individual

Matthew Clay

18,779

9,921

9,921

Darren Rix

11,768

6,217

6,217

 

 

Enquiries

 

Forterra plc:

+44 (0) 1604 707 600

Shatish Dasani (CFO)

Ben Guyatt (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Matthew Clay

2.

Reason for the notification

a)

Position/status

Managing Director Bespoke Products (PDMR)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

(i) Acquisition of 18,779 shares in the Company following the vesting of an award granted under the DABP on 1 June 2016; and (ii) subsequent sale of 8,858 shares to cover PAYE/NI liabilities arising from such vesting. The remainder of the shares (9,921) are being retained

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

(i) Acquisition

Nil

18,779

(ii) Sale

£3.06

8,858

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 (i) Acquisition

Nil

18,779

Nil

 (ii) Sale

£3.06

8,858

£27,105.48

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Darren Rix

2.

Reason for the notification

a)

Position/status

Strategy and Development Director (PDMR)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

(i) Acquisition of 11,768 shares in the Company following the vesting of an award granted under the DABP on 1 June 2016; and (ii) subsequent sale of 5,551 shares to cover PAYE/NI liabilities arising from such vesting. The remainder of the shares (6,217) are being retained

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

(i) Acquisition

Nil

11,768

(ii) Sale

£3.06

5,551

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 (i) Acquisition

Nil

11,768

Nil

 (ii) Sale

£3.06

5,551

£16,986.06

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUCGCUPRGPM
Date   Source Headline
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company
26th Jan 20218:15 amRNSProgressive publishes new research
26th Jan 20217:00 amRNSTrading Statement
6th Jan 20217:21 amRNSEmployee Benefit Trust Share Purchase
6th Jan 20217:21 amRNSDirector/PDMR Shareholding
4th Jan 20219:29 amRNSHolding(s) in Company
8th Dec 20202:28 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20201:00 pmRNSEmployee Benefit Trust Share Purchase
24th Nov 20208:24 amRNSProgressive publishes new research
24th Nov 20207:00 amRNSTrading Statement
5th Nov 20205:09 pmRNSHolding(s) in Company
9th Oct 20203:45 pmRNSGrant of Options under 2020 SAYE Scheme
18th Sep 202010:12 amRNSGrant under Performance Share Plan
18th Sep 20209:40 amRNSHolding(s) in Company
14th Sep 20201:50 pmRNSProgressive publishes new research
14th Sep 20209:05 amRNSHolding(s) in Company
10th Sep 20207:00 amRNS2020 HALF YEAR RESULTS
7th Sep 20205:34 pmRNSHolding(s) in Company
14th Aug 20201:45 pmRNSHolding(s) in Company
30th Jul 20204:54 pmRNSHolding(s) in Company
16th Jul 202010:09 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.